Related Experiment Videos

Immunotherapy of metastatic melanoma with interleukin-2

¹Jeanne B. Lambert Laboratory for Cancer Research, Mount Sinai School of Medicine, New York, NY 10029.

The Mount Sinai Journal of Medicine, New York

|May 1, 1992

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Postremission therapy in older patients with de novo acute myeloid leukemia: a randomized trial comparing mitoxantrone and intermediate-dose cytarabine with standard-dose cytarabine.

Blood·2001

Interleukin-2 plus chemotherapy for patients with metastatic melanoma.

Melanoma research·2000

An evaluation of combinations of diaziquone, etoposide and mitoxantrone in the treatment of adults with relapsed or refractory acute myeloid leukemia: results of 8722, a randomized phase II study conducted by Cancer and Leukemia Group B.

Leukemia·1998

Sequential mitoxantrone, daunorubicin, and cytosine arabinoside for patients with newly diagnosed acute myelocytic leukemia.

American journal of hematology·1997

Surgical treatment of spinal cord compression from epidural metastasis.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·1995

Granulocyte-macrophage colony-stimulating factor after initial chemotherapy for elderly patients with primary acute myelogenous leukemia. Cancer and Leukemia Group B.

The New England journal of medicine·1995

See all related articles